title: An immunohistochemical evaluation of BMP-2, -4, osteopontin, osteocalcin and PCNA between ossifying fibromas of the jaws and peripheral cemento-ossifying fibromas on the gingiva.
abstract: The present study examined histological difference between ossifying fibromas (OF, n=5) and peripheral cemento-ossifying fibromas (PCOF, n=7). Bone morphogenetic proteins (BMP)-2 and -4, osteopontin (OPN), osteocalcin (OCN) and proliferating cell nuclear antigen (PCNA) were used for the immunohistochemical examinations. Oxytalan fibers present at the periodontal tissue were stained to determine the tumor cell origin. Many OFs showed high immunohistochemical reactions for BMP-2, -4 and OPN compared to those of PCOFs. PCNA index (IP) of OFs was significantly higher than that of PCOFs. All the PCOFs showed a high expression of oxytalan fibers. Only two OFs exhibited a small number of oxytalan fibers. These results suggest that PCOF has only little ability to form hard tissue and seems to be a reactive lesion. The expression of oxytalan fibers reveals that OF does not only originate from periodontal tissue.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Biopathological Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8525, Japan.
authors.forename: Akiko
authors.initials: A
authors.lastname: Ono
authors.forename: Goichi
authors.initials: G
authors.lastname: Tsukamoto
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Nagatsuka
authors.forename: Yasuto
authors.initials: Y
authors.lastname: Yoshihama
authors.forename: Rosario Santos
authors.initials: RS
authors.lastname: Rivera
authors.forename: Miki
authors.initials: M
authors.lastname: Katsurano
authors.forename: Mayumi
authors.initials: M
authors.lastname: Yao
authors.forename: Akira
authors.initials: A
authors.lastname: Sasaki
mesh_terms: D000293:Adolescent; D000328:Adult; D055396:Bone Morphogenetic Protein 2; D055415:Bone Morphogenetic Protein 4; D019485:Bone Morphogenetic Proteins / Q000378:metabolism*; D002114:Calcinosis / Q000378:metabolism / Q000473:pathology; D002648:Child; D005260:Female; D018214:Fibroma, Ossifying / Q000378:metabolism* / Q000473:pathology; D005885:Gingival Hyperplasia / Q000378:metabolism / Q000473:pathology; D005887:Gingival Neoplasms / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007573:Jaw Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000378:metabolism*; D053495:Osteopontin / Q000378:metabolism*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
chemical_list: C525718:BMP2 protein, human; C525809:BMP4 protein, human; D055396:Bone Morphogenetic Protein 2; D055415:Bone Morphogenetic Protein 4; D019485:Bone Morphogenetic Proteins; D018809:Proliferating Cell Nuclear Antigen; D016212:Transforming Growth Factor beta; D015675:Osteocalcin; D053495:Osteopontin